Global Gel Stents Market
Major driving factors of global gel stents market are transforming healthcare system such as hospitals/clinics integrating latest technology, spike in private insurance coverage and increasing geriatric population with glaucoma defect.
The global stent market is anticipated to reach USD 17.25 billion by 2024. The global gel stent market tends to reach USD 0.37 billion by 2024 expanding at a CAGR of 30% over the forecast period owing to the advancement in glaucoma surgeries. Research segment contributes around 40% in global gel stent market and eye research institutes dominate the end user segment of global gel stent market. APAC gel stents market tends to pose the highest growth rate due to rising interest in advanced and novel technology with minimally invasive procedure.
Browse Full Report: Gel Stents Market
Glaukos iStent: Changing landscape of Glaucoma
Global glaucoma market was valued USD 5 billion in 2016, with minimal innovation on pharmaceutical, surgery and device side. iStent is the smallest implant to be implanted in the body known to be the first micro invasive glaucoma surgery device (MIGS device). The first MIGS device was approved by FDA in 2012 and has been implanted in over 300,000 eyes and exceeded USD 71 million from the sales of iStents.
“Global Gel Stents Market Outlook 2024” contains detailed overview of the global gel stents market in terms of market segmentation by clinical trials and end-user.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.
This market report also includes competitive outlook of some of the major players of the global gel stents market which includes profiling of companies like Innfocus, Allergan, Aquesys, Glaukos, etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments. Overall, the report represents comprehensive synopsis on the global gel stent market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions. Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Backed up by reliable research and impactful statistics, our business solutions empower our clients to grow at a fast pace despite unsettling fluctuations in the market. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.